Tyrosine phosphorylation regulates cytokine-induced dimerization of STAT proteins. Serine phosphorylation has also been found to occur in a number of STAT proteins, including Stat1, Sat3, Stat4, Stat5a, Stat5b and Stat6, and was shown to be important for maximal transcriptional activation mediated by Stat1, Stat3 and Stat4, but not for Stat5a or Stat5b. As these latter proteins were studied in transiently transfected COS-7 cells stimulated with prolactin, we sought to further investigate the signi®cance of their serine phosphorylation in a more physiologically based system in response to IL-2. Both Stat5a and Stat5b were rapidly phosphorylated on serine in response to IL-2 and the phosphorylation site in Stat5a was mapped to Ser780, which is not conserved in Stat5b. In vitro studies with reporter constructs, and experiments in which wild-type and mutant Stat5a retroviruses were used to transduce Stat5a-de®cient splenocytes revealed that the serine mutant constructs were not diminished in their ability to mediate IL-2 signaling and if anything exhibited augmented proliferative capability. Thus, in contrast to the apparent importance of serine phosphorylation for transcriptional activation by Stat1, Stat3 and Stat4 in response to IFN, IL-6 and IL-12 respectively, serine phosphorylation of Stat5a does not enhance Stat5a-mediated signaling in response to IL-2.
Introduction
Cytokines and IFN signal through a number of signaling pathways, including the Jak±STAT pathway (1, 2) . Following the binding of these molecules to their receptors, Janus family tyrosine kinases (Jak kinases) are activated, resulting in the tyrosine phosphorylation of tyrosine residues on receptors, some of which can serve as docking sites for the binding of STAT proteins, which bind to the phosphorylated receptor via their SH2 domains (1, 2) . The STAT proteins in turn are phosphorylated on a conserved tyrosine. When the STAT proteins dissociate from the receptor, they then can dimerize, translocate to the nucleus, bind regulatory sequences in target genes and act as transcription factors (1, 2) . Tyrosine phosphorylation of the STAT proteins is essential for their homo-or heterodimerization by an SH2 domain-mediated mechanism in which the SH2 domain of each STAT protein monomer interacts with the phosphorylated tyrosine in the other monomer. A C-terminal region of STAT proteins is required for transactivation (1, 2) .
In addition to Jak kinase-mediated tyrosine phosphorylation, it has become evident that a number of STAT proteins can be phosphorylated on serine [reviewed in detail in (3) ]. Stat1 and Stat3 were the ®rst STAT noted to contain phosphoserine based on phosphoamino acid analysis (3±5). Subsequently, Stat4, Stat5a and Stat5b were also noted to contain phosphoserine (3,6±10) . The initial studies on Stat1 and Stat3 revealed a conserved residue, Ser727, as the phosphorylation site (5) . This residue is within the transactivation domain and was identi®ed as biologically important, as its mutation to alanine in the context of either Stat1 or Stat3 resulted in a partial decrease in cytokine-induced transcriptional activation (11, 12) . This was shown for IFN-g in the case of Stat1 (13) , and for IFN-a and IL-6 in the case of Stat3 (14) . Similar effects have been shown for mutation of Ser721 of Stat4, the homologous residue (15) .
In contrast to the apparent importance of these serine residues in Stat1, Stat3 and Stat4, the situation for Stat5 proteins is somewhat different and is perhaps analogous to Stat6 where multiple serine residues in the transactivation domain are phosphorylated in response to IL-4, but the functional signi®cance of this is not clear (16, 17) . In the context of prolactin signaling, it was found that Ser725 of murine Stat5a was constitutively phosphorylated in COS-7 cells and Nb2 lymphocytes, whereas phosphorylation of Ser730 of Stat5b was potently induced by prolactin (8, 9 ). An independent study revealed that Ser779 in murine Stat5a was constitutively phosphorylated in multiple tissues, and that mutagenesis of Ser725 and Ser779 did not affect prolactininduced activation of a b-casein reporter construct, but, interestingly, a Ser725 mutant exhibited sustained DNA binding activity in transiently transfected COS-7 cells (10). Another study revealed that phosphorylation of Ser725 and Ser779 of murine Stat5a cooperatively suppressed prolactinstimulated transcription from the b-casein promoter in COS-7 and MCF-7 mammary cells (18) . Consistent with this observation, mutation of Ser779, alone or in combination with Ser725, of Stat5a and mutation of Ser730 of Stat5b led to an increase in growth hormone-induced b-casein promoter activity (19) . In contrast, these mutations caused decreased activity of a reporter construct containing four copies of a Stat5-binding site derived from the promoter of the rat ntcp gene, suggesting that serine phosphorylation of Stat5 proteins may modulate the expression of target genes based on the promoter context (19) . We have now investigated serine phosphorylation of Stat5a and Stat5b in response to IL-2. We identi®ed serine phosphorylation of both proteins by phosphoamino acid analysis, but both mass spectrometry and radioactive sequencing of H 3 32 PO 4 -labeled cells only revealed a serine-phosphorylated site (Ser780) in human Stat5a. Mutagenesis of Stat5a at positions 725 and 780 and reconstitution experiments in murine splenocytes showed that the mutants were at least as active as wild-type Stat5a, underscoring the difference in the importance of serine phosphorylation of Stat5a versus Stat1/Stat3.
Methods

Metabolic labeling and immunoprecipitation of Stat5a phosphoproteins
YT cells (1.5 Q 10 7 /well) were cultured overnight in RPMI 1640 media supplemented with 2% FBS and labeled with H 3 32 PO 4 (1 mCi/ml, 8500±9120 Ci/mmol; NEN, Boston, MA) for 4 h at 37°C in phosphate-free RPMI 1640 containing 2% dialyzed FBS. 32 P-labeled cells were incubated in the absence or presence of IL-2 (100 U/ml,~2 nM) for 15 min at 37°C. Cells were then collected, washed and lysed in 1 ml of lysis buffer (50 mM Tris±HCl, pH 7.4 containing 1% Triton X-100, 10% glycerol, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EGTA, 50 mM NaF, 1 mM Na 3 VO 4 , 1 mM phenylethylsulfonyl uoride and 10 mg/ml leupeptin). Insoluble material was pelleted by centrifugation, lysates pre-cleared with 25 ml Protein A±agarose (Pierce, Rockford, IL) for 60 min at 4°C, and then immunoprecipitated overnight at 4°C with antibodies to Stat5a and Stat5b. Immune complexes were collected by incubation with 25 ml of Protein A±agarose for 60 min at 4°C, washed 5 times with 1 ml ice cold washing buffer [50 mM Tris, pH 8.5; 1% (v/v) Triton X-100, 1% deoxycholate, 0.1% SDS, 150 mM NaCl and 0.2% sodium azide], and once each with 1 ml of ice-cold PBS and H 2 O. Washed immune complexes were suspended in 25 ml of SDS sample buffer and heated for 7.5 min at 90°C. Released immunoprecipitated proteins were resolved by SDS±PAGE through 8% Tris±glycine gels (Invitrogen, Carlsbad, CA). Electrophoresed phosphoproteins were transferred to Immobilon-P membranes (Millipore, Bedford, MA) and the Stat5 proteins identi®ed by autoradiography using XAR ®lm (Kodak, Rochester, NY).
Phosphoamino acid analysis of immunoprecipitated, phosphorylated protein
Phosphorylated Stat5 protein bands located by autoradiography were excised from the Immobilon-P membranes and subjected to hydrolysis in 150 ml of 6 N HCl at 100°C for 90 min, thereby liberating 32 P-labeled phosphoamino acids from the membrane. The hydrolysates were evaporated to dryness and reconstituted in 12 ml of electrophoresis buffer [7.8% acetic acid and 2.5% formic acid (v/v), pH 1.9] containing unlabeled phosphoamino acid standards (Sigma, St Louis, MO). Samples were spotted onto 20 Q 20 cm DEAE cellulosecoated glass TLC plates (Merck/EM Science, Gibbstown, NJ) and 32 P-labeled phosphoamino acids resolved by two-dimensional horizontal electrophoresis according to an established procedure (20) using the HTLE-7000 peptide mapping system (CBS Scienti®c, Del Mar, CA). Brie¯y, sample-spotted TLC plates were pre-wet with pH 1.9 electrophoresis buffer and electrophoresed in the ®rst dimension for 20 min at 1500 V. After air-drying, TLC plates were premoistened with pH 3.5 electrophoresis buffer [5% acetic acid, 0.5% pyridine (v/v), 0.5 mM EDTA, pH 3.5], rotated 90°and electrophoresed in the second dimension for 18 min at 1350 V. The locations of resolved phosphoamino acid standards were visualized by ninhydrin staining and co-migrating radiolabeled phosphoamino acids were subsequently detected by autoradiography.
Mapping of protein phosphorylation sites
Final puri®cation of radiolabeled Stat5a and Stat5b was achieved by immunoprecipitation and SDS±PAGE. Gels were ®xed, dried and exposed to X-ray ®lm to visualize the radiolabeled proteins. In-gel digestion of the proteins with trypsin (Roche Diagnostics, Indianapolis, IN) was performed as described (21) . The resultant peptides were separated using reversed-phase HPLC on a microbore C 8 column (Vydac, Hesperia, CA) and an aliquot of each collected fraction subjected to scintillation counting. Individual radio-active peptides were subjected to covalent Edman degradation on a Sequelon AA membrane (Perseptive Biosystems, Cambridge, MA) with a protein sequencer, model 492 (Applied Biosystems, Foster City, CA). The ATZ-amino acids were extracted from the membrane with neat tri¯uoroacetic acid and scintillation counted. Radioactive pro®les for each sequencing run were compared to theoretical peptide sequences derived from Stat5a and Stat5b respectively. For con®rmation of the phosphorylation sites, synthetic peptides were prepared corresponding to the possible Stat5a tryptic phosphopeptides. These peptides were mixed with the radioactive tryptic digest and detected by UV absorption using reversed-phase HPLC.
Mass spectrometry for the identi®cation of phosphorylation sites
The procedure for identifying phosphorylation sites was previously described (22) . Brie¯y, matrix-assisted laser desorption/ionization mass spectrometry (MALDI/TOF) with delayed extraction (Voyager-DE; Perseptive Biosystems, Framingham, MA) was used for the identi®cation of phosphopeptides. Electrospray ion trap mass spectrometry (LCQ; Finnigan, San Jose, CA) coupled on-line with a microbore HPLC (Magic 2002, Auburn, CA) were used for the identi®ca-tion of the phosphorylation site. A monitor C18 column (5 mm particle diameter, 150 A Ê pore size, 0.2 Q 50 mm dimension) was used for the on-line liquid chromatography/mass spectrometry/mass spectrometry (LC/MS/MS) analysis.
Constructs and mutagenesis
Human Stat5a and murine Stat5a were subcloned into the XhoI site of pGFP-RV, a retroviral vector (23) . Mutations of Ser726 and/or Ser780 in human Stat5a and Ser725 and/or Ser779 in murine Stat5a were introduced in their respective original vectors using the Quick Change site-directed mutagenesis kit (Stratagene, La Jolla, CA), the sequences of the mutant constructs were con®rmed, and the inserts were then subcloned into the pGFP-RV vector.
Retroviral transduction of splenocytes from Stat5a ±/± mice
The mice used in this study were F2 or F3 animals derived from Stat5a heterozygous crosses of mixed background (129 SvEv Q NIH Black Swiss SvCv Q BALB/c) animals [(24) kindly provided by Dr Lothar Hennighausen]. All experiments were performed under protocols approved by the National Institutes of Health Animal Use and Care Committees and followed the National Institutes of Health Guidelines`Using Animals in Intramural Research'. Splenic cells were isolated from 8-to 12-week-old Stat5a ±/± mice, and suspended in RPMI 1640 supplemented with 10% FBS, 2 mM L-glutamine, antibiotics and 50 mM 2-mercaptoethanol (complete RPMI) containing 10 mM HEPES (pH 7.0). Lymphocytes were isolated using Histopaque 1.119 (Sigma) and T cells were then puri®ed by panning on dishes coated with goat anti-mouse IgG (100 mg/ml in PBS for 1 h at room temperature). Splenic T cells were resuspended in complete RPMI containing 1 mg/ml anti-CD28 (BD PharMingen, San Diego, CA) and 1 nM recombinant human IL-2 (Hoffmann La Roche, Nutley, NJ), and were activated for 24 h by culturing in dishes precoated with anti-CD3 (1 mg/ml, 37°C for 1.5 h).
Retroviruses harboring wild-type human or murine Stat5a or their serine mutants were packaged in 293T cells by co-transfection of Stat5a-expressing pGFP-RV and pCL eco , the retroviral packaging vector (25) . For each infection, 2 ml of ®ltered retroviral supernatant was supplemented with 4 mg/ml polybrene and added to 1 Q 10 6 splenic T cells. The cells were centrifuged at 2500 r.p.m. at 30°C for 45 min. The supernatant was removed and the cells were cultured in full RPMI supplemented with 0.5 mg/ml anti-CD3, 1 mg/ml anti-CD28 and 1 nM IL-2. The retroviral infection was repeated 24 h later, and the cells were maintained in full RPMI containing 1 nM IL-2 for 7±10 days before¯ow cytometric analysis and proliferation assays.
Retrovirus-infected splenic T cells were stained and analyzed on a FACSort (Becton Dickinson, San Jose, CA) using CellQuest software as previously described (26) . Phycoerythrin (PE)-conjugated anti-IL-2Ra (PC61) and rat IgG1 (a l isotype-matched control antibody; BD PharMingen) were used for direct staining.
Proliferation assays
After three washes with PBS, retrovirus-infected splenic T cells (2Q10 5 cells/well) were cultured in complete RPMI 1640 with or without 1 nM IL-2 for 24 h in 96-well plates and pulsed with 1 mCi of [ 3 H]thymidine (6.7 mCi/mmol; NEN) for the last 12 h of culture. Radioactivity incorporated into cells was collected on printed glass ®ber ®lters with a cell harvester and was counted using a Trilux 1450 micro-b-counter (Wallac, Turku, Finland).
Results and discussion
To evaluate IL-2-induced phosphorylation of Stat5 proteins, two equal aliquots (15 Q 10 6 cells each) of YT cells were labeled with H 3 32 PO 4 and then either not stimulated or stimulated with IL-2. Cells were then lysed and lysates immunoprecipitated with antisera to Stat5a or Stat5b. By one-dimensional analysis, IL-2 resulted in an increase in the overall level of phosphorylation of each Stat5 protein (Fig. 1) . The amino acid speci®city of this phosphorylation was determined by a two-dimensional electrophoretic phosphoamino acid analysis (Fig. 2) . In the absence of IL-2, basal serine phosphorylation was detected for both Stat5a and Stat5b. Stimulation with IL-2 increased serine phosphorylation (2.5-, 3.2-and 3.7-fold for Stat5a and 1.7-, 3.7-and 8.9-fold for Stat5b in three independent experiments) and induced robust tyrosine phosphorylation. Threonine phosphorylation was not detected in either untreated or IL-2-treated samples. IL-2-induced increases in serine and tyrosine phosphorylation were also observed in NK3.3 cells (data not shown). IL-2-stimulated phosphorylation of Stat5a and Stat5b was also evaluated in human peripheral blood lymphocytes. IL-2 uniformly induced serine and tyrosine phosphorylation of Stat5a; in the case of Stat5b, while induction of tyrosine phosphorylation was seen in all three donors examined, induction of serine phosphorylation was more variable (data not shown). The reason for the difference in sensitivity of Stat5b serine versus tyrosine phosphorylation is unknown.
To determine the speci®c sites of phosphorylation, YT cells were labeled with H 3 32 PO 4 , Stat5a and Stat5b were immunoprecipitated, and radiolabeled bands corresponding to Stat5a and Stat5b were excised. In-gel digestion of the proteins was performed with trypsin, peptides separated by HPLC and then subjected to Edman degradation. Radioactivity contained in each fraction was counted as detailed in Methods. For Stat5a, both before (data not shown) and after IL-2 stimulation (Fig. 3A) , a radioactive peak was detected in fractions 34±35. An additional peak of radioactivity was identi®ed in fraction 29 only after IL-2 stimulation (Fig. 3A) . Sequencing of each of these peaks showed that the 32 P-labeled residue was in cycle 5 of the fraction 29 peptide (Fig. 3B) and cycle 2 of the fraction 34±35 peptide (Fig. 3C) . Examination of the various possible tryptic peptide sequences derived from Stat5a with a tyrosine residue in position (sequencing cycle) 5 (Fig. 3B ) allowed us to unequivocally identify the radioactive peptide in fraction 29 (Fig. 3A) as A 690 VDGpYVKPQIK 700 . This peptide includes the known Y694 tyrosine phosphorylation site of Stat5a. Based on the elution pro®le from the HPLC column and the fact that it carries a radioactive amino acid in sequencing cycle 2 (Fig. 3C) , we hypothesized that fractions 34±35 (Fig. 3A) corresponded to the phosphopeptide L 779 pSPPAGLFTSAR 790 , which includes Ser780, a serine residue that is not conserved in Stat5b. Analogous to fraction 29 for Stat5a, a strongly phosphorylated peptide was detected in fraction 26 of Stat5b (data not shown). This site corresponds to A 695 VDGpYVK 701 , which includes the known Stat5b Y699 tyrosine phosphorylation residue (data not shown). Unexpectedly, however, we could not identify a second radioactive peptide for Stat5b, even though two-dimensional phosphoamino acid analysis had revealed serine phosphorylation. This ®nding might be explained by the inability to elute the phosphorylated peptide from the gel.
In order to con®rm these ®ndings, we used mass spectrometry to analyze in vivo phosphorylation of Stat5 in YT cells using an experimental procedure described previously (22) . Two phosphopeptides were identi®ed upon treatment of the trypsin digest with a calf intestine phosphatase from an in-gel trypsin digestion of the Stat5a protein. Figure 3(A) shows a peak corresponding to a phosphorylated peptide. The phosphorylated peptides were sequenced by LC/MS/MS to identify the phosphorylation sites as Ser780 (see legend for explanation) and Y699 (data not shown) respectively. Analogous to the radioactive phosphorylated peptide analysis, for Stat5b, Fig. 1 and subjected to acid hydrolysis. The phosphoamino acids thus released were developed on DEAE cellulose-coated plates and autoradiographed. pSer and pTyr stand for phosphorylated serine and phosphorylated tyrosine respectively. mass spectrometry analysis only revealed the Y699 peptide, but no serine-phosphorylated peptide (data not shown).
Having identi®ed Ser780 as the site of serine phosphorylation in human Stat5a, we next investigated whether either this residue or Ser726, the human homologue of murine Ser725, which Yamashita et al. identi®ed as a Stat5a phosphorylation site (9), or both were required for Stat5a-dependent transcription in response to IL-2. As an assay system, we used retrovirus-mediated transduction of splenocytes from Stat5a ±/± mice. IL-2-induced proliferation and IL-2Ra expression were then evaluated. As splenocytes from Stat5a ±/± mice are known to exhibit diminished IL-2-induced IL-2Ra expression (27) , we tested the ability of retrovirus-transduced Stat5a to rescue this phenotype. IL-2Ra expression in GFP-RV vector-transduced Stat5a ±/± splenocytes was similar to that observed in noninfected cells (Fig. 5A) , while the cells infected by a retrovirus harboring wild-type Stat5a showed greatly elevated IL-2Ra expression (Fig. 5B) . The higher percentage of green¯uores-cent protein (GFP) + cells in the Stat5-transduced group can be attributed to a higher proliferation rate of those cells in which Stat5 expression is restored (discussed below). Transduction with human Stat5aS726A, S780A or S726A/S780A mutants all potently restored IL-2Ra expression in Stat5a ±/± splenocytes (Fig. 5C, D and E, and Table 1 ). Interestingly, in most experiments, the mutants were if anything more effective than wild-type Stat5a (Table 1) . Proliferation assays were also performed 7±10 days after retrovirus infection when GFP + cells comprised >70% of the viable cells. As shown in Table 2 , transduction of wild-type Stat5a or the S726A, S780A or S726A/S780A mutants of human Stat5a each yielded reasonably similar levels. At the highest concentrations of IL-2, the double mutant yielded slightly higher levels of proliferation. Similar results for IL-2Ra expression (Table 1) and proliferation  (Table 2) were obtained with wild-type murine Stat5a, with S725A or S779A mutants, or with S725A/S779A double mutants. Thus, mutation of serine residues in Stat5a did not diminish Stat5a function. If anything, particularly for the double mutant, both basal and maximal functional activities were slightly higher for the serine mutants, although the basis for and signi®cance of this ®nding remains unclear. It will be interesting to determine if there are interacting protein(s), whose interaction is affected by serine phosphorylation of Stat5, that directly or indirectly affect proliferation. There tended to be increased proliferation in Stat5a (wild-type or serine mutants)-transduced splenocytes compared with those transduced with pRV alone. However, because the cells are pre-activated, this could re¯ect a Stat5-dependent effect of endogenous IL-2 that persisted even after resting the cells.
This study represents the ®rst report of the serine phosphorylation of human Stat5a and Stat5b, and the ®rst to speci®cally investigate Stat5 phosphorylation sites in response to IL-2. As noted above, in studies focusing on Fig. 3 . Reversed-phase HPLC of the tryptic digest of radiolabeled Stat5a (A) and radioactive Edman degradation of the radioactive peptides eluting in fractions 29 (B) and 34±35 (C). In (A), the tryptic digest peptide mixture was fractionated on a reversed-phase C 8 column and 10% of each 1-min fraction was counted. In (B) and (C), the radioactive peptides were bonded covalently to the sequencing membrane and subjected to Edman degradation. The membrane extracts from each sequencing cycle were counted. prolactin and growth hormone, Ser779 and Ser725 were separately identi®ed as sites of phosphorylation for Stat5a, while Ser730 was found to be a phosphorylation site for Stat5b (8±10,19). As noted above, initial studies showed no functional de®cit in reporter assays when these serines were mutated to alanines (9, 10) , while more recent studies suggest different regulatory effects depending on the promoter context (18, 19) . Because these functional studies were all performed using transient transfection and in view of the important functional roles for serine phosphorylation reported for Stat1, Stat3 and Stat4 (4, 5, 15) , we sought to further investigate the role of serine phosphorylation for Stat5 proteins in the context of IL-2 and to use a more physiologically based assay system. Although both Stat5a and Stat5b appeared to be phosphorylated on serine, we could only map a site in Stat5a as Ser780 (the human homologue of Ser779). It is conceivable that sites in Stat5b and other site(s) in Stat5a could be phosphorylated, but that they could not be identi®ed either by the experimental approaches used. The failure to identify such sites might result, for example, from the phosphorylation of multiple sites, with each individual site being phosphorylated at too low a stoichiometry to allow detection.
To investigate the functional signi®cance of serine phosphorylation of Stat5a, we mutated each of the sites identi®ed in this study as well as those found by others in previous studies. The effect of site-directed mutagenesis was evaluated using reporter assays in cell lines (data not shown) and by reconstitution of primary splenocytes from Stat5a ±/± mice, where we evaluated cellular proliferation in response to IL-2. No defects were found in any of the assays. These data indicate that, at least for the activities examined, serine phosphorylation of Stat5a is not essential for IL-2 signaling. In fact, unexpectedly, in ®ve of six experiments, there was somewhat augmented CD25 expression in splenocytes reconstituted with mutated Stat5a. This is consistent with the observations that mutation of Ser725 and/or Ser779 to Ala in murine Stat5a showed prolonged prolactin-induced DNA Splenic T cells from Stat5a ±/± mice were isolated and infected with retroviruses as described in Methods. After subsequent expansion for 7±10 days in the presence of 1 nM IL-2, the cells were analyzed for expression of IL-2Ra. Shown are the mean¯uorescent intensities of IL-2Ra±PE on GFP + cells. Each peak corresponds to a tryptic peptide of the indicated mol. wt. The height of each peak shows the relative rather than absolute abundance. As expected, the dephosphorylated ion at m/z 2275.21 increases in relative abundance after treatment with CIP (solid circle). There appears to be comparable amounts of phosphorylated and unphosphorylated protein originally present, although MALDI is imprecise in such quantitation. Note that trypsin inef®ciently cleaves after Arg770 due to the adjacent Pro771 and inef®ciently cleaves after Arg778, presumably because of the phosphorylation of Ser780. (B) The LC/MS/MS (often referred to as liquid chromatograph/mass spectrometry 2 ) spectrum of the phosphopeptide identi®ed in (A) at 2355.6 + 2 H (hydrogen ions) = 2357.6. When this is divided by the full charge of +3, one gets 786 (3+ charged). A window of T2 Da was used to select the ion. Ser780 was identi®ed as the site of phosphorylation. The ions marked with D signify that 98 a.m.u. corresponding to H 3 PO 4 has been lost. The b and y nomenclature (30) used corresponds to the typical cleavage points of the peptide. The b ions correspond to the amido C±N cleavage points (between the carbonyl and the adjacent a-amino group at each peptide bond) with the charge being retained by the N-terminal fragment; similarly, the y ions correspond to the same cleavage with the charge retained by the C-terminal fragment, plus 2 H atoms that have migrated to the N-terminal Nitrogen atom of each resulting peptide fragment. Thus, the y ions correspond to sequential N-terminal deletions of 1 or more amino acids. Speci®cally, for example, b 7 comprises amino acids 770±776, whereas y 7 comprises residues 784±790. The y n+ 10 ion refers to the y 10 ion that carries n positive charges; therefore, its mass will be the (y 10 mass + [n ± 1] H)/n [the charge]; thus y 2+ 10 has a mass of (y 10 + 1H)/2. The b 7 , y 10 and y 2+ 10 ions have masses that indicate that they do not contain phosphate, restricting the phosphate site to Ser777 or Ser780. Ions at y 2+ 14 (770.6), and yD 2+ 14 and b 11 , b 2+ 11 , and bD 11 con®rm this. The ion at 1086 for yD 11 allows assignment of the phosphate to Ser780. binding activity (10, 18) and delayed dephosphorylation of Tyr694 (10) . In addition, mutation of Ser730 in Stat5b caused increased Stat5 DNA-binding activity and an increase in growth hormone-induced b-casein promoter activity (19) . Collectively, these results point to a possible role of serine phosphorylation in limiting the duration of Stat5 signals, although the possible signi®cance of this ®nding and mechanism require additional investigation. Nevertheless, based on reconstitution experiments in normal murine splenocytes, we can conclude that the functional signi®cance of serine phosphorylation of Stat5 proteins is distinctive from its role in Stat1, Stat3 and Stat4 signaling, where it has been shown to serve a positive regulatory function. It is interesting that while Stat1, Stat3 and Stat4 share a Pro±Met±Ser±Pro motif, the Stat5a Ser725 residue is in a Pro±Ser±Pro motif, whereas the Ser780 peptide is closer to the C-terminus and contains an Arg±Leu± Ser±Pro sequence. The fact that these motifs are different from those present in Stat1, Stat3 and Stat4 is consistent with a potentially different function, as well as with the potential utilization of different serine/threonine kinases. Evolutionarily, it has been suggested that STAT proteins can be divided into two classes, B-type STAT and A-type STAT, with Stat1, Stat2, Stat3 and Stat4 falling into the former category, and Stat5a, Stat5b and Stat6 falling into the latter (28, 29) . Consistent with this categorization, none of these latter A-type STAT proteins contain the Pro±Met±Ser±Pro motif nor has serine phosphorylation been shown to be essential for their transactivation function or DNA binding. Thus, the importance of serine phosphorylation for different STAT proteins may correlate with evolutionary considerations.
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